Home >
Medicine Info >
Fibroprist Tablet
Loading interface...

Fibroprist Tablet

Manufactured byAKUMENTIS HEALTHCARE LTD
ContainsUlipristal Acetate
Description
Fibroprist Tablet is a medication that is used for intermittent treatment of moderate to severe symptoms of uterine fibroids (abnormal growth in the uterus) and also as an emergency contraceptive. In adult women with fibroids who have not reached menopause (cessation of menstruation), lower doses (5mg/10mg/15mg) are preferred for treatment. As an emergency contraceptive, Fibroprist Tablet is used in high doses (30mg). Fibroprist Tablet reduces the size of fibroids by blocking the effects of progesterone. Progesterone is a sex hormone involved in the menstrual cycle, pregnancy and the formation of eggs (primary female gamete). As a contraceptive, it prevents the release of the egg during ovulation. Fibroprist Tablet may cause certain side effects like nausea, missed periods, weakness, headache, dizziness, etc. Talk to your doctor if these symptoms persist for a long time. Do not take Fibroprist Tablet if you have ever been allergic to it. This medicine should not be given to children under the age of 18 years. Fibroprist Tablet should be taken only if your doctor has prescribed it. The dose of the medicine and duration of treatment is determined by your health condition and other underlying diseases. Fibroprist Tablet should not be used if you are pregnant, planning a pregnancy or are breastfeeding. Do not take Fibroprist Tablet if you have serious health conditions like liver problems or cancer (cervical, ovarian uterine).
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Fibroprist Tablet

  • Menstrual bleeding
  • Headache
  • Nausea
  • Stomach cramps and pain
  • Unusual tiredness and weakness
  • Vomiting
  • Dizziness

Uses of Fibroprist Tablet

What is it prescribed for?

  • Uterine fibroids
  • Emergency contraception
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    Fibroprist Tablet takes 1-2 hours to show its effect.
  • How long do the effects of this medicine last?
    Fibroprist Tablet remains effective in the body for 9-10 days in the treatment of fibroids. When used as an emergency contraceptive (30mg), it stays up to 8 days in your body.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Fibroprist Tablet.
  • Can this medicine be taken during pregnancy?
    Do not take Fibroprist Tablet if you are pregnant or planning a pregnancy.
  • Can this medicine be taken while breast-feeding?
    It is not known whether Fibroprist Tablet passes into breast milk or if it could affect your baby. If you are breastfeeding, it is advisable that you talk to your doctor before taking this medicine.

Allergy

Do not take Fibroprist Tablet if you are allergic to it. Inform your doctor if you have a history of Fibroprist Tablet allergy. If you notice any symptoms such as a skin rash, itching/swelling anywhere on your body, dizziness, breathing difficulty, etc., seek medical attention immediately.

Cancers

Avoid using Fibroprist Tablet in cases of suspected or confirmed cancer (ovarian, cervical, breast, or uterine). If you have a family history of cancer, then your clinical condition will be closely monitored by your doctor.

Asthma

If you have asthma and are on steroids, you should not take Fibroprist Tablet.
Warnings for special population

Pregnancy

Do not take Fibroprist Tablet if you are pregnant or planning a pregnancy.

Breast-feeding

It is not known whether Fibroprist Tablet passes into breast milk or if it could affect your baby. If you are breastfeeding, it is advisable that you talk to your doctor before taking this medicine.
General warnings

Driving or operating machinery

Fibroprist Tablet may cause dizziness or drowsiness. Do not perform any activity such as driving a vehicle or operating a machine after taking this medicine

Sexually transmitted diseases

Fibroprist Tablet is not effective in treating or preventing diseases that are transmitted via sexual contact.

Use in children

This medicine should not be given to children under the age of 18 years due to a lack of safety and efficacy data.

Missed Dose

If you miss a dose of Fibroprist Tablet, take it as soon as you remember. Do not take the missed dose if it is almost time for your next dose. Skip the missed dose and continue with your regular schedule.

Overdose

Never take more than the prescribed dose of Fibroprist Tablet. In case you have taken an overdose of this medicine, kindly seek emergency medical attention.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Edoxaban

Phenytoin

Carbamazepine

Ketoconazole

Erythromycin

Disease interactions

Liver Disease

Fibroprist Tablet has to be used with caution if you have liver disease. Please consult your doctor before taking the medicine. You will also be advised to undergo liver function tests (LFT) while you are on treatment with Fibroprist Tablet.
Food interactions
Avoid taking grapefruit juice while taking Fibroprist Tablet as grapefruit juice interferes with the action of the medicine and can cause serious side effects.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Uterine Fibroids: Take Fibroprist Tablet as advised by your doctor. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor. Emergency contraception: This medicine should always be taken after consulting with your doctor. It has to be taken within 5 days (120 hours) of unprotected sexual intercourse. In case you vomit within 3 hours after taking this medicine, contact your doctor immediately for further instructions. Do not take more than the prescribed dose of Fibroprist Tablet.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
The lower doses (5mg/10mg/15mg) of Fibroprist Tablet work by blocking the effects of progesterone (a female hormone that plays a major role in developing fibroids) and thereby reduces the size of fibroids. At higher doses (30mg), it works as an emergency contraceptive by preventing the release of an egg.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Progesterone receptor modulators, Contraceptives

Schedule

Schedule H

Medicines.org.uk. 2021. ellaOne 30 mg - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 13 July 2021].

https://www.medicines.org.uk/emc/product/6657/smpc>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 13 July 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022474s000lbl.pdf>

Dailymed.nlm.nih.gov. 2021. DailyMed - ELLA- ulipristal acetate tablet. [online] Available at: < [Accessed 13 July 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=052bfe45-c485-49e5-8fc4-51990b2efba4>

Drugs, H., 2021. Ulipristal: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 13 July 2021].

https://medlineplus.gov/druginfo/meds/a610020.html>

Pubchem.ncbi.nlm.nih.gov. 2021. Ulipristal. [online] Available at: < [Accessed 13 July 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/159811-51-5>

Medicines.org.uk. 2021. Esmya 5 mg Tablets (ulipristal acetate) - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 27 July 2021].

https://www.medicines.org.uk/emc/product/3951/smpc>

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. (n.d.). [online] . Available at: ‌

https://www.ema.europa.eu/en/documents/product-information/esmya-epar-product-information_en.pdf.
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 23 Aug 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.